Inflammation is as an important component of intestinal tumorigenesis. The activation of Toll-like receptor 4 (TLR4) signalling promotes inflammation in colitis of mice, but the role of TLR4 in intestinal tumorigenesis is not yet clear. About 80%-90% of colorectal tumours contain inactivating mutations in the adenomatous polyposis coli (Apc) tumour suppressor, and intestinal adenoma carcinogenesis in familial adenomatous polyposis (FAP) is also closely related to the germline mutations in Apc. The Apc Min/+ (multiple intestinal neoplasia) model mouse is a well-utilized model of FAP, an inherited form of intestinal cancer. In this study, Apc Min/+ intestinal adenoma mice were generated on TLR4-sufficient and TLR4-deficient backgrounds to investigate the carcinogenic effect of TLR4 in mouse gut by comparing mice survival, peripheral blood cells, bone marrow haematopoietic precursor cells and numbers of polyps in the guts of Apc Min/+ WT and Apc Min/+ TLR4 −/− mice. The results revealed that TLR4
| INTRODUC TI ON
Colorectal cancer (CRC) has become the second leading cause of cancer-related death in developed countries. The transitional treatments include surgery, combined chemotherapy and radiation therapy. 1 Currently, the use of targeted therapies is limited to patients with stage IV metastatic colon cancer. 2 Thus, the identification of new targets for CRC therapy is needed.
Previous studies have reported that the Apc/Wnt pathway is an attractive target for the treatment of CRC. 3 The adenomatous polyposis coli (Apc) tumour suppressor is mutated in 80%-90% of human colorectal tumours. 4 Apc, along with axin and glycogen synthase kinase 3b (GSK3b), assembles a protein complex that targets β-catenin for degradation, which is regulated by Wnt signalling. 5 This is the main mechanism of Apc mutation leading to tumorigenesis, as the resulting increased availability of β-catenin causes changes in the transcriptional process to decrease the amount of cell differentiation. 6 TLRs are sensors for pathogen-associated molecular patterns (PAMPs) and play important roles in initializing inflammation. 7 Toll-like receptor 4 (TLR4) is the main mediator of responses to lipopolysaccharide (LPS) both in vitro and in vivo. 8 It has been reported that inflammatory responses contribute to intestinal carcinogenesis through multiple mechanisms, for example TLR4 signalling activates NF-κB through the MYD88 pathway, [9] [10] [11] and it is well known that patients with inflammatory bowel disease are at higher risk of CRC. 12 TLR4/MYD88 signalling contributes to CRC tumorigenesis not only in colitis-associated cancer, but also in sporadic CRC. 13 Disorders of intestinal microflora can also lead to intestinal carcinogenesis. Chen 
et al reported that
Fusobacterium nucleatum activates beta-catenin signalling in CRC via a TLR4/P-PAK1 cascade. 14 However , it has been reported that TLR4-deficient C3H/HeJ mice developed more tumours relative to TLR4-normal C3H/HeN mice. 15 This suggests that TLR4 may also have a role in inhibiting tumorigenesis. It is therefore evident that the specific regulation mechanism of TLR4 signalling that promotes or inhibits tumorigenesis is unclear. In the present study, Apc Min/+ (multiple intestinal neoplasia) mice were generated on TLR4-sufficient and TLR4-deficient backgrounds to explore the role of this pathway in spontaneous intestinal tumorigenesis.
Apc Min/+ mice carry a single mutant Apc allele and develop benign adenomas in the gut by 4-5 months of age. 3 In this study, high-throughput sequencing was used to screen out the production of TLR4 signalling downstream genes and validate them in a variety of ways. These data may provide an insight into the role of TLR4 in intestinal tumorigenesis.
| ME THODS

| Mice
Adult WT mice (C57BL/6 wild type) were purchased from the Chinese Academy of Science (Shanghai, China). TLR4 −/− , Apc Min/+ WT and Apc Min/+ TLR4 −/− mice were provided by the Model Animal Research Center of Nanjing University (Nanjing, China).
All mice were bred and maintained under specific pathogen-free (SPF) conditions in the laboratory of the Animal Center of Second Military Medical University. In the survival studies, the number of mice per group is shown in each figure, and 3 mice per group were used in all other experiments. RNA-Seq analysis included 3 pairs of colon samples of Apc Min/+ WT and Apc Min/+ TLR4 −/− mice. All the mice used in the experiments were 4-6 months old. This study was approved by an ethics committee and followed the tenants of the Declaration of Helsinki.
| Cell culture
CT-26 cells 16 (mouse intestinal cancer cell lines) and SW1116 cells 17 (human intestinal cancer cell lines) used in this study were obtained from the Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (Shanghai, China). Cells were cultured in Dulbecco's modified Eagle's medium (DMEM; PAA, Austria) containing 10% foetal calf serum (PAA) at 37°C in a humidified atmosphere of 5% CO 2 . All cell lines used in this study had been cultured for less than 6 months when the experiments were performed.
| Analysis of peripheral blood
To explore the peripheral blood conditions, the mice were eyebled using heparin-coated capillary tubes to take blood while the mice were under anaesthesia. The blood was transferred to Eppendorf (EP) tubes with K2-EDTA and inverted multiple times. A small animal blood cell counter was used to measure blood cells.
| Measurement of bone marrow haematopoietic precursor cells
Femur bone marrow was taken from each group of mice to make bone marrow nucleated cell suspensions. After the bone marrow nucleated cell suspensions were diluted to the appropriate concentration, the corresponding fluorescently labelled antibody was added in a ratio of 1:100 (GMP: Lin − c-Kit + FcγRII/III hi CD34 hi ; CMP:
Lin − c-Kit + FcγRII/III lo CD34 hi ; MEP: Lin − c-Kit + FcγRII/III lo CD34 lo ; EP1: Ter119 − CD71 hi ; EP2: Ter119 hi CD71 hi ; EP3: Ter119 hi CD71 med ; EP4:
Ter119 hi CD71 lo ). A CD34-FcγRII/III kit and Ter119-CD71 kit were provided by the eBioscience Corporation (USA). The suspensions were mixed well and incubated for 20 min at room temperature in the dark; PBS was then added to mix and dilute, and flow cytometry (Beckman Coulter, USA) was used for testing. 18, 19 
| Histological study
Gut tissues were dehydrated in an ascending grade of ethanol, then cleared and embedded in paraffin wax. Serial sections of 2-7 microns thick were obtained using a rotatory microtome. The deparaffinized sections were stained routinely using the H & E staining method.
Ki67 kits were applied to assess the proliferative capacity of intestinal epithelial crypt cells. 20 TUNEL kits were applied to assess the apoptosis of intestinal epithelial crypt cells. 21 Photomicrographs of the desired sections were obtained using a digital research photographic microscope (Thermo Corporation, USA). 
| RNA-Seq analysis
| Quantitative real-time PCR (RT-qPCR)
Total RNAs from tissue samples were isolated using an RNA isolation and purification reagent kit provided by GenePharma Corporation 
| Cytokine measurement via enzyme-linked immunosorbent assay (ELISA)
The amounts of cytokines in the serum of mice or CT-26 cells were measured by ELISA kits provided by Dakewe Biotech Corporation were normalized for the number of cytokines per mg of total protein in the supernatant. 24 In the experiments of IL-6 and GM-CSF mediated by TLR4, the mice were abdominally injected with 1 mg/ kg bodyweight LPS, and the CT-26 cells were treated with 1 ng/ mL of LPS 24 hours before measuring the IL6 and GM-CSF with the ELISA kit.
| Flow multifactor detection assay
The mean fluorescence intensity of the cytokines in the serum of each group was measured by a multifactor detection reagent kit 25 (Dakewe Biotech Corporation, Shenzhen, China), and flow cytometry (Beckman Coulter, USA) was utilized for testing.
| MTT assay
Relative cell viability was analysed using tetrazolium salt 3-(4, 5-dimethylthiazol-2-yl)22, 5-diphenyltetrazolium bromide(MTT) (Dojindo Corporation, Shanghai, China). The CT-26 cells were treated with 100 ng/mL of LPS, IL6, GM-CSF, IL11, CD40, TNF, CCL3, MMP9 and S100A8/A9 24 hours before MTT analysis. The SW1116 cells were treated with 100 ng/mL of LPS, IL6, GM-CSF and IL11 24 hours before MTT analysis. For analysis, 20 μl of MTT substrate was added to each well. The plates were returned to the incubator for an additional 4 hours at 37°C with 5% CO 2 .
The medium was removed, and the cells were solubilized in 150 μl of dimethyl sulphoxide before colorimetric analysis was performed (wavelength: 490 nm). One plate was analysed immediately after the cells adhered (approximately 4 hours after plating), and the remaining plates were analysed every day for the next 3 days. 26 
| Apoptosis analysis
Cell apoptosis was analysed using apoptosis detection kits 27 (TransGen Biotech, Beijing, China). The CT-26 cells were treated with 100 ng/mL of LPS, IL6, GM-CSF, IL11, CD40, TNF, CCL3, MMP9 and S100A8/A9 for 24 hours, and were then exposed to 6 Gy radiation irradiation or treatment with the chemotherapy drug paclitaxel. The SW1116 cells were treated with 100 ng/mL of LPS, IL6, GM-CSF and IL11 for 24 hours, and were then exposed to 6 Gy radiation irradiation or treatment with the chemotherapy drug paclitaxel. After 24 hours, the CT-26 and SW1116 cells were stained with Annexin V-FITC/propidium (PI) (eBioscience Corporation, USA), and cell ap- 
| Amounts of MDSC analysis in spleen and bone marrow of mice
Femur bone marrow was taken from each group of mice to make bone marrow nucleated cell suspensions (BMCs). The spleen taken from each group of mice was mashed. After the BMCs and spleen suspensions were diluted to the appropriate concentration, the corresponding fluorescently labelled antibody CD11b/Gr 1 (eBioscience Corporation, USA) was added. The suspensions were mixed well and incubated for 20 min at room temperature in the dark; PBS was then added to mix and dilute, and flow cytometry (Beckman Coulter, USA) was used for testing.
| Statistical analysis
Comparisons among experimental groups and relevant controls (but not survival studies) were performed using Student's t test or one-way analysis of variance. Survival studies were performed on GraphPad Prism software (GraphPad Software Inc, La Jolla, CA, USA).
Differences in survival studies of the various groups of mice were assessed using the Kaplan-Meier method and Cox regression analysis.
Statistical analysis generated a P-value and statistic value for each analysis; P < .05 was considered a statistically significant difference. Figure 4A ). We selected 47 down-regulated differential genes with fold change greater than 2 and P-value less than 0.05 in the Apc Min/+ TLR4 −/− model mice ( Figure 4B ). The selected genes were more commonly used in our experimental system and had a certain role in promoting tumour proliferation. Volcano plots were created to visualize the significant differential up-regulation and down-regulation genes in the gut tumours of Apc Min/+ TLR4 −/− mice compared with Apc Min/+ WT mice ( Figure 4C) . A differential gene KEGG pathway enrichment analysis was also conducted. Analysis of the KEGG database revealed differences between the Apc Min/+ WT and Apc Min/+ TLR4 −/− mice in 255 pathways. The top 20 total pathways with a number of differential genes greater than 2 ( Figure S1A ) were screened out, and it was found that differential genes were much more expressed in two pathways: cytokine-cytokine receptor interaction and pathways in cancer ( Figure S1B The results suggest that, compared with Apc Min/+ WT mice, IL6, GM-CSF and IL11 were down-regulated in Apc Min/+ TLR4 −/− mice, and the genes generated by intestinal polyps were more significantly down-regulated ( Figure 5B ). Additionally, 13 factors in the serum were compared between Apc Min/+ and Apc Min/+ TLR4 −/− mice by flow multifactor detection assay. Compared with the Apc Min/+ WT mice, these 13 cytokines decreased to some degree in the Apc Min/+ TLR4 −/− mice, and IL-6 and GM-CSF down-regulation was also more obvious ( Figure S2A,B ).
| RE SULTS
| TLR4 −/− inhibited spontaneous intestinal tumorigenesis in Apc Min/+ model mice
| Expression patterns and KEGG pathway enrichment analysis of differential genes in gut tumours of Apc Min/+ WT controls and Apc Min/+ TLR4 −/− mice
| IL-6 and GM-CSF were mediated by TLR4 in WT or Apc Min/+ mice in protein levels
To explore the expression levels of IL6 and GM-CSF regulated by TLR4 signalling, three levels of experimental studies were conducted: in the serum and colons of the mice, and in the colon cancer F I G U R E 4 Differential genes in intestinal tumours were analysed by high-throughput RNA-Seq. (A) Cluster analysis chart. Red indicates that genes were up-regulated, and green indicates that genes were down-regulated. (B) The obvious down-regulated differential genes of concern in Apc Min/+ TLR4 −/− model mice were selected. (C) Volcano plot that displays the dysregulated genes in intestinal tumours of Apc Min/+ WT and Apc Min/+ TLR4 −/− mice. The vertical grey lines correspond to twofold up-and down-regulation, and the horizontal grey line represents a P-value of 0.05. The red points indicate up-regulated genes in tumours of Apc Min/+ TLR4 −/− mice, and the green points indicate down-regulated genes in tumours of Apc Min/+ TLR4 −/− mice F I G U R E 5 Validation assays of down-regulated differential genes that were of concern in intestinal tumours of Apc Min/+ TLR4 −/− mice. Figure 6B ).
These data suggest that the expressions of IL6 and GM-CSF were regulated by TLR4 signalling in protein levels.
| Functional study of down-regulation factors such as IL6 and GM-CSF in intestinal cancer cell lines
CT-26 cells belong to the mouse intestinal cancer cell line. CT-26 cells were treated with LPS (TLR4 agonist), IL-6, IL-11, GM-CSF, CD40, TNF, CCL3, MMP9, S100A8 and S100A9, and cell viability F I G U R E 6 IL-6 and GM-CSF were mediated by TLR4 in WT or Apc Min/+ mice. (A) The left panels are, respectively, the expression levels of IL6 and GM-CSF in the serum of WT with or without LPS treatment (1 mg/kg bodyweight), and Apc Min/+ mice with or without LPS treatment (1 mg/kg bodyweight). The middle panels are the expression levels of IL6 and GM-CSF in the colons of Apc Min/+ mice with or without LPS treatment (1 mg/kg bodyweight). The right panels are the expression levels of IL6 and GM-CSF in CT-26 cells with or without LPS treatment (1 ng/mL). (B) The left panels are, respectively, the expression levels of IL6 and GM-CSF in the serum of Apc Min/+ mice with or without LPS treatment (1 mg/kg bodyweight), and Apc Min/+ TLR4 −/− mice with or without LPS treatment (1 mg/kg bodyweight). The middle panels are, respectively, the expression levels of IL6 and GM-CSF in the serum of WT mice with or without LPS treatment (1 mg/kg bodyweight), and TLR4 −/− mice with or without LPS treatment (1 mg/kg bodyweight). The right panels are, respectively, the expression levels of IL6 and GM-CSF in the colons of Apc Min/+ mice with or without LPS treatment (1 mg/kg bodyweight), and Apc Min/+ TLR4 −/− mice with or without LPS treatment (1 mg/kg bodyweight). *P < .05, **P < .01, ***P < .001; NS: No significant difference detected. All data were detected by ELISA assay was detected after 24 h using MTT assay. The results showed that, except for TNF, MMP9 and CD40, the other cytokines effectively enhanced CT-26 cell viability, especially cytokines TLR4, IL-6 and GM-CSF ( Figure 7A,B) . Next, the apoptosis rates of the cytokines-treated CT-26 cells were examined after the administration of radiation and the chemotherapeutic drug paclitaxel by Annexin V/PI double staining. It was found that, compared with the control, the apoptosis rates of cytokines-treated CT-26 cells decreased after radiation and chemotherapy ( Figure 7C-F) . Similar experiments were also conducted on the human intestinal cancer cell line SW1116 cell. It was found that IL6, GM-CSF, IL11 and LPS effectively enhanced SW1116 cell viability ( Figure S3A,B) , and, compared with the control, the apoptosis rates of IL6, GM-CSF, IL11 and LPS-treated SW1116 cells decreased after radiation and chemotherapy ( Figure S3C,D) . These data show that the inhibition of the activity of cytokines such as IL-6 and GM-CSF could effectively improve the sensitivity of radiotherapy and chemotherapy to colon cancer cells. Based on these results, a network map of F I G U R E 7 Functional study of down-regulation factors in mouse intestinal cancer CT-26 cell line. (A) CT-26 cells were treated with 100 ng/mL LPS, IL6, IL11, GM-CSF, CD40, TNF, CCL3, MMP9 and S100A8/9, and the cell viability was detected at days 0, 1, 2 and 3 by MMT assay. (B) Statistical analysis of cell viability of cytokines-treated CT-26 cells. (C) CT-26 cells were treated with 100 ng/mL LPS, IL6, IL11, GM-CSF, CCL3 and S100A8/9 for 24 h, then exposed to 6 Gy radiation. After 24 h, the apoptosis rates of cytokines-treated CT-26 cells were detected with Annexin V/PI double staining by flow cytometry. (D) Statistical analysis of Ann V-FITC positive of cytokines-treated CT-26 cells with 6 Gy radiation. (E) CT-26 cells were treated with 100 ng/mL LPS, IL6, IL11, GM-CSF, CCL3 and S100A8/9 for 24 h, then exposed to paclitaxel. After 24 h, the apoptosis rates of cytokines-treated CT-26 cells were detected with Annexin V/PI double staining by flow cytometry. (F) Statistical analysis of apoptosis rates of cytokines-treated CT-26 cells with paclitaxel. (G) Network interaction map of TLR4 and its core downstream factors promoting spontaneous intestinal tumorigenesis.*P < .05, **P < .01, NS: No significant difference detected TLR4 and its regulatory genes that promoted mouse gut tissue proliferation and apoptosis in intestinal tumour formation and development was constructed ( Figure 7G ).
| D ISCUSS I ON
Vogelstein et al 29 held that patients with germline mutations of Apc did not necessarily develop CRC, along with additional risk factors, such as inflammation induction leading to tumour development. TLR4 pathway-mediated immune response is an important mechanism that aggravates intestinal injury in mouse ulcerative colitis models. 30 In the present study, Apc Min/+ intestinal adenoma mice were generated on TLR4-sufficient and TLR4-deficient backgrounds to investigate the carcinogenic effect of TLR4 by comparing mice survival, peripheral blood cells, bone marrow haematopoietic precursor cells and numbers of polyps in the guts of Apc Min/+ WT and Apc Min/+ TLR4 mice. The results revealed that TLR4 had a critical role in promoting spontaneous intestinal tumorigenesis. To study the downstream genes involved in the promotion of intestinal tumorigenesis by TLR4 signalling, high-throughput RNA sequencing was utilized to screen for dysregulated genes in gut tumours between Apc Min/+ WT and Apc Min/+ TLR4 mice. After a series of validation experiments for the concerned genes, it was found that IL6, GM-CSF (CSF2), IL11, CCL3, S100A8 and S100A9 were significantly decreased in the gut tumours of Apc Min/+ TLR4 −/− mice compared with Apc Min/+ WT mice. Combined with the KEGG enrichment data, it can be determined that TLR4 might promote intestinal tumorigenesis by activating cytokine-cytokine receptor interaction and pathways in cancer signalling pathways. In the functional study of core downregulation factors, it was found that IL6, GM-CSF, IL11, CCL3 and S100A8/9 increased the viability and decreased the apoptosis rate of colon cancer cells with irradiation and chemical treatment. The effects of IL6 and GM-CSF were the most obvious.
The tumour-promoting effect of inflammation is now widely recognized and better understood. 31 The NF-κB-IL6-Stat3 cascade is an important inflammatory regulator of the proliferation of tumourinitiating intestinal epithelial cells. 32 Baltgalvis et al 33 significantly up-regulated the expression levels of IL6 in the serum or colons of Apc Min/+ WT mice and in the CT26 cells. However, the expression levels of IL6 activated by LPS presented no significant changes in WT or Apc Min/+ TLR4 −/− mice. These data suggest that TLR4 was the upstream molecule of IL6 that promoted tumour development, and it has been reported that TLR4 and NF-κB signalling are required to control the regulation of the IL-6 mRNA stabilizing molecule Arid5a. 34 GM-CSF was initially classified as a haematopoietic growth factor. In the inflammatory process, GM-CSF serves as a communication conduit between tissue-invading lymphocytes and myeloid cells, and GM-CSF-activated phagocytes are well equipped to cause tissue damage. 35 Chen et al 36 reported that GM-CSFtreated cancer cells exhibited an enhanced ability of motility both in vitro and in vivo, and that chronic exposure of intestinal cancer cells to GM-CSF led to the occurrence of intestinal epithelium to mesenchymal transition (EMT). Ripk3 signalling promotes intestinal tumours by up-regulating cytokines IL23 and IL1β, which are required for expanding IL-17-producing T cells through I-MDSCs, a distinct MDSC subset that is dependent on GM-CSF. 37 Ripk3 activity is mediated by TLR4. 38 We ever used CD11b/Gr 1 double staining to detect the expression of MDSC in spleen and bone marrow of WT, Apc Min/+ , Apc Min/+ TLR4 −/− mice by flow cytometry.
The results suggested that the expression level of MDSC in spleen and bone marrow of Apc Min/+ mice was higher than that in WT or Apc Min/+ TLR4 −/− mice ( Figure S4A 
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